MTCH1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.980500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.496500E-02
Normal-vs-Stage2
1.94846000000082E-05
Normal-vs-Stage3
2.543400E-01
Normal-vs-Stage4
7.024600E-01
Stage1-vs-Stage2
4.067800E-01
Stage1-vs-Stage3
7.519200E-01
Stage1-vs-Stage4
7.789800E-02
Stage2-vs-Stage3
2.875000E-01
Stage2-vs-Stage4
1.779000E-01
Stage3-vs-Stage4
2.184800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.195300E-04
Normal-vs-AfricanAmerican
1.593990E-01
Normal-vs-Asian
2.526400E-01
Caucasian-vs-AfricanAmerican
7.059400E-01
Caucasian-vs-Asian
8.275400E-01
AfricanAmerican-vs-Asian
8.530000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.716000E-03
Normal-vs-Female
1.218100E-02
Male-vs-Female
9.836200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.389800E-02
Normal-vs-Age(41-60Yrs)
4.825600E-01
Normal-vs-Age(61-80Yrs)
1.161250E-04
Normal-vs-Age(81-100Yrs)
2.965200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.120400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.956000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.234600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.629800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.579400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.825000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.067900E-02
Normal-vs-Daily Drinker
1.642880E-04
Normal-vs-Weekly Drinker
3.117400E-01
Normal-vs-Occasional Drinker
2.935200E-01
Normal-vs-Social Drinker
6.218400E-03
Non Drinker-vs-Daily Drinker
2.272800E-01
Non Drinker-vs-Weekly Drinker
5.322000E-01
Non Drinker-vs-Occasional Drinker
4.881600E-02
Non Drinker-vs-Social Drinker
7.258200E-01
Daily Drinker-vs-Weekly Drinker
8.221700E-02
Daily Drinker-vs-Occasional Drinker
8.699500E-03
Daily Drinker-vs-Social Drinker
3.948800E-01
Weekly Drinker-vs-Occasional Drinker
1.472620E-01
Weekly Drinker-vs-Social Drinker
3.213800E-01
Occasional Drinker-vs-Social Drinker
2.839900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.961800E-01
Normal-vs-Grade 2
9.340600E-01
Normal-vs-Grade 3
9.405400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.919400E-01
Grade 1-vs-Grade 3
7.460800E-01
Grade 1-vs-Grade 4
7.961800E-01
Grade 2-vs-Grade 3
8.696000E-01
Grade 2-vs-Grade 4
9.340600E-01
Grade 3-vs-Grade 4
9.405400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.779710E-02
Normal-vs-NonDiabetic
4.277500E-03
Diabetic-vs-NonDiabetic
5.111400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.824200E-02
Normal-vs-NoPancreatitis
2.255600E-03
Pancreatitis-vs-NoPancreatitis
6.870200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.093400E-01
Normal-vs-N1
1.77045999999459E-05
N0-vs-N1
2.943800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.960400E-01
Normal-vs-TP53-NonMutant
1.691010E-01
TP53-Mutant-vs-TP53-NonMutant
4.198400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
